Japanese universal health care faces a crisis in cancer treatment.
Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: yfujiwar@ncc.go.jp.
Yasuhiro
Y
Fujiwara
Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kan
K
Yonemori
Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
Taro
T
Shibata
Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Natsuko
N
Okita
Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan.
Nobuko
N
Ushirozawa
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D017277:Drug Approval; D016527:Drug Costs; D015507:Drugs, Investigational / Q000191:economics / Q000627:therapeutic use*; D006291:Health Policy / Q000191:economics / Q000331:legislation & jurisprudence; D006297:Health Services Accessibility; D006801:Humans; D007564:Japan; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D011050:Policy Making; D016730:Program Development; D016896:Treatment Outcome; D019472:Universal Health Insurance / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration
D000970:Antineoplastic Agents; D015507:Drugs, Investigational